{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:18:18Z","timestamp":1786119498508,"version":"build-2736575974"},"reference-count":41,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1097\/cji.0b013e3181d75c20","type":"journal-article","created":{"date-parts":[[2010,5,12]],"date-time":"2010-05-12T03:59:58Z","timestamp":1273636798000},"page":"500-509","source":"Crossref","is-referenced-by-count":18,"title":["Efficient Inhibition of Human B-cell Lymphoma in SCID Mice by Synergistic Antitumor Effect of Human 4-1BB Ligand\/Anti-CD20 Fusion Proteins and Anti-CD3\/Anti-CD20 Diabodies"],"prefix":"10.1097","volume":"33","author":[{"given":"Rong","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenguo","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongxing","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanjun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huifang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruizan","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongmei","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunzheng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenping","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongsheng","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-8-20210312","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1089\/scd.1.1996.5.537","article-title":"Minimal residual disease: detection, clinical relevance, and treatment strategies","volume":"5","author":"Dwenger","year":"1996","journal-title":"J Hematother"},{"key":"R2-8-20210312","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.4049\/jimmunol.125.4.1678","article-title":"Characterization of a human B lymphocyte specific antigen","volume":"125","author":"Stashenko","year":"1980","journal-title":"J Immunol"},{"key":"R3-8-20210312","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1038\/nm1322","article-title":"Signal amplification in molecular imaging by pretargeting a multivalent bispecific diabodies","volume":"11","author":"Sharkey","year":"2005","journal-title":"Nat Med"},{"key":"R4-8-20210312","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/01.cji.0000199193.29048.56","article-title":"Immune suppression in the tumor microenvironment","volume":"29","author":"Gajewski","year":"2006","journal-title":"J Immunother"},{"key":"R5-8-20210312","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1007\/s00262-004-0540-x","article-title":"Escape from immunotherapy: possible mechanisms that influence tumor regression\/progression","volume":"53","author":"Ahmad","year":"2004","journal-title":"Cancer Immunol Immunother"},{"key":"R6-8-20210312","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/nrc1586","article-title":"Immunosuppressive networks in the tumour environment and their therapeutic relevance","volume":"5","author":"Zou","year":"2005","journal-title":"Nat Rev Cancer"},{"key":"R7-8-20210312","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1084\/jem.173.3.721","article-title":"Binding of the B cell activation antigen B7 to CD28 co-stimulates T cell proliferation and interleukin-2 mRNA accumulation","volume":"173","author":"Linsley","year":"1999","journal-title":"J Exp Med"},{"key":"R8-8-20210312","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/sj.cgt.7700438","article-title":"Autocrine costimulation: tumor-specific CD28-mediated costimulation of T cells by in situ production of a bifunctional B7-anti-CEA diabody fusion protein","volume":"9","author":"Blanco","year":"2002","journal-title":"Cancer Gene Ther"},{"key":"R9-8-20210312","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1146\/annurev.immunol.23.021704.115611","article-title":"The B7 family revisited","volume":"23","author":"Greenwald","year":"2005","journal-title":"Annu Rev Immunol"},{"key":"R10-8-20210312","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/nri1148","article-title":"Co-stimulatory members of the TNFR family: keys to effective T-cell immunity?","volume":"3","author":"Croft","year":"2003","journal-title":"Nat Rev Immunol"},{"key":"R11-8-20210312","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/nrc2051","article-title":"Immunostimulatory monoclonal antibodies for cancer therapy","volume":"7","author":"Melero","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"R12-8-20210312","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s00262-005-0081-y","article-title":"Renewed interest in cancer immunotherapy with the tumor necrosis factor superfamily molecules","volume":"55","author":"Tamada","year":"2006","journal-title":"Cancer Immunol Immunother"},{"key":"R13-8-20210312","doi-asserted-by":"crossref","first-page":"8252","DOI":"10.4049\/jimmunol.179.12.8252","article-title":"4-1BBL induces TNF receptor-associated factor 1-dependent Bim modulation in human T cells and is a critical component in the costimulation-dependent rescue of functionally impaired HIV-specific CD8T cells","volume":"179","author":"Wang","year":"2007","journal-title":"J Immunol"},{"key":"R14-8-20210312","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/j.1365-3083.2007.01994.x","article-title":"Agonistic anti-4-1BB antibody promotes the expansion of natural regulatory T cells while maintaining Foxp3 expression","volume":"66","author":"Zhang","year":"2007","journal-title":"Scand J Immunol"},{"key":"R15-8-20210312","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/S1016-8478(23)10765-5","article-title":"Marked expansion of CD11c+CD8+ T-cells in melanoma-bearing mice induced by anti-4-1BB monoclonal antibody","volume":"24","author":"Ju","year":"2007","journal-title":"Mol Cells"},{"key":"R16-8-20210312","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/cmi.2008.6","article-title":"Establishment and characterization of a cell based artificial antigen-presenting cell for expansion and activation of CD8+ T cells ex vivo","volume":"5","author":"Gong","year":"2008","journal-title":"Cell Mol Immunol"},{"key":"R17-8-20210312","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0304-3835(01)00758-3","article-title":"Efficient inhibition of human B-cell lymphoma xenografts with an anti-CD20\u00d7anti-CD3 bispecific diabody","volume":"177","author":"Xiong","year":"2002","journal-title":"Cancer Lett"},{"key":"R18-8-20210312","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1182\/blood.V90.7.2723","article-title":"In vitro cellular drug resistance and prognosis in newly diagnosed childhood acute lymphoblastic leukemia","volume":"90","author":"Kaspers","year":"1997","journal-title":"Blood"},{"key":"R19-8-20210312","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1128\/CDLI.8.6.1131-1135.2001","article-title":"Calcein-acetyoxymethyl cytotoxicity assay: standardization of a method allowing additional analyses on recovered effectors cells and supernatants","volume":"8","author":"Neri","year":"2001","journal-title":"Clin Diagn Lab Immunol"},{"key":"R20-8-20210312","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/sj.jid.5700001","article-title":"Cytotoxic T cells","volume":"126","author":"Andersen","year":"2006","journal-title":"J Invest Dermatol"},{"key":"R21-8-20210312","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s00262-007-0348-6","article-title":"A bispecific diabody directed against prostate-specific membrane antigen and CD3 induces T-cell mediated lysis of prostate cancer cells","volume":"57","author":"B\u00fchler","year":"2008","journal-title":"Cancer Immunol Immunother"},{"key":"R22-8-20210312","doi-asserted-by":"crossref","first-page":"888","DOI":"10.4049\/jimmunol.165.2.888","article-title":"Treatment of human B cell lymphoma xenografts with a CD3\u00d7CD19 diabody and T cells","volume":"165","author":"Cochlovius","year":"2000","journal-title":"J Immunol"},{"key":"R23-8-20210312","doi-asserted-by":"crossref","first-page":"4036","DOI":"10.1158\/1078-0432.CCR-06-0059","article-title":"Humanization of the bispecific epidermal growth factor receptor\u00d7CD3 diabody and its efficacy as a potential clinical reagent","volume":"12","author":"Asano","year":"2006","journal-title":"Clin Cancer Res"},{"key":"R24-8-20210312","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/sj.leu.2403267","article-title":"Efficient inhibition of multidrug-resistant human tumors with a recombinant bispecific anti-P-glycoprotein\u00d7anti-CD3 disbody","volume":"18","author":"Gao","year":"2004","journal-title":"Leukemia"},{"key":"R25-8-20210312","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1038\/bjc.1994.366","article-title":"Phase I study of intravenously applied bispecific antibody in renal cell cancer patients receiving subcutaneous interleukin 2","volume":"70","author":"Kroesen","year":"1994","journal-title":"Br J Cancer"},{"key":"R26-8-20210312","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1158\/1078-0432.CCR-06-2343","article-title":"Targeted and untargeted CD137L fusion proteins for the immunotherapy of experimental solid tumors","volume":"13","author":"Zhang","year":"2007","journal-title":"Clin Cancer Res"},{"key":"R27-8-20210312","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1097\/CJI.0b013e31818353e9","article-title":"A novel antibody-4-1BBL fusion protein for targeted costimulation in cancer immunotherapy","volume":"31","author":"M\u00fcller","year":"2008","journal-title":"J Immunother"},{"key":"R28-8-20210312","first-page":"4336","article-title":"Cure of Burkitt's lymphoma in severe combined immunodeficiency mice by T cells, tetravalent CD3\u00d7CD19 tandem diabody, and CD28 costimulation","volume":"60","author":"Cochlovius","year":"2000","journal-title":"Cancer Res"},{"key":"R29-8-20210312","doi-asserted-by":"crossref","first-page":"12650","DOI":"10.1074\/jbc.M700820200","article-title":"Improved pharmacokinetics of recombinant bispecific antibody molecules by fusion to human serum albumin","volume":"282","author":"M\u00fcller","year":"2007","journal-title":"J Biol Chem"},{"key":"R30-8-20210312","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0955-0674(99)80027-1","article-title":"Costimulatory regulation of T cell function","volume":"11","author":"Chambers","year":"1999","journal-title":"Curr Opin Cell Biol"},{"key":"R31-8-20210312","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1089\/scd.1.1995.4.447","article-title":"Treatment of heterotransplanted Hodgkin's tumors in SCID mice by a combination of human NK or T cells and bispecific antibodies","volume":"4","author":"Renner","year":"1995","journal-title":"J Hematother"},{"key":"R32-8-20210312","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/PL00014047","article-title":"Immune recruitment by bispecific antibodies for the treatment of Hodgkin disease","volume":"46","author":"da Costa","year":"2000","journal-title":"Cancer Chemother Pharmacol"},{"key":"R33-8-20210312","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1093\/intimm\/dxm106","article-title":"Co-stimulation with 4-1BB ligand allows extended T-cell proliferation, synergizes with CD80\/CD86 and can reactivate anergic T cells","volume":"19","author":"Habib-Agahi","year":"2007","journal-title":"Int Immunol"},{"key":"R34-8-20210312","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1002\/(SICI)1521-4141(199803)28:03<1116::AID-IMMU1116>3.0.CO;2-A","article-title":"Amplification of tumor immunity by gene transfer of the co-stimulatory 4-1BB ligand: synergy with the CD28 co-stimulatory pathway","volume":"28","author":"Melero","year":"1998","journal-title":"Eur J Immunol"},{"key":"R35-8-20210312","doi-asserted-by":"crossref","first-page":"5003","DOI":"10.4049\/jimmunol.162.8.5003","article-title":"4-1BBL cooperates with B7-1 and B7-2 in converting a B cell lymphoma cell line into a long-lasting antitumor vaccine","volume":"162","author":"Guinn","year":"1999","journal-title":"J Immunol"},{"key":"R36-8-20210312","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/jgm.834","article-title":"Comparative analysis of antitumor activity of CD40L, RANKL, and 4-1BBL in vivo following intratumoral administration of viral vectors or transduced dendritic cells","volume":"8","author":"Yurkovetsky","year":"2006","journal-title":"J Gene Med"},{"key":"R37-8-20210312","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/ni1029","article-title":"Priming of naive T cells inside tumors leads to eradication of established tumors","volume":"5","author":"Yu","year":"2004","journal-title":"Nat Immunol"},{"key":"R38-8-20210312","first-page":"511","article-title":"Construction and expression of eukaryotic expression vector of human 4-1 BB ligand gene in tumor cells and its antitumor activity in vitro","volume":"23","author":"Lu","year":"2007","journal-title":"Chin J Cell Mol Immunol"},{"key":"R39-8-20210312","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1093\/intimm\/dxf080","article-title":"4-1BB co-stimulation enhances humanCD8+T cell priming by augmenting the proliferation and survival of effector CD8+T cells","volume":"14","author":"Laderach","year":"2002","journal-title":"Int Immunol"},{"key":"R40-8-20210312","doi-asserted-by":"crossref","first-page":"4882","DOI":"10.4049\/jimmunol.169.9.4882","article-title":"4-1BB promotes the survival of CD8+ T lymphocytes by increasing expression of Bcl-xL and Bfl-1","volume":"169","author":"Lee","year":"2002","journal-title":"J Immunol"},{"key":"R41-8-20210312","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/nri1083","article-title":"The ABCs of granule-mediated cytotoxicity: new weapons in the arsenal","volume":"3","author":"Lieberman","year":"2003","journal-title":"Nat Rev Immunol"}],"container-title":["Journal of Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/CJI.0b013e3181d75c20","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:24:01Z","timestamp":1786040641000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00002371-201006000-00008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6]]},"references-count":41,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/cji.0b013e3181d75c20","relation":{},"ISSN":["1524-9557"],"issn-type":[{"value":"1524-9557","type":"print"}],"subject":[],"published":{"date-parts":[[2010,6]]}}}